This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Bethany Naomi Deshpande: Innovator in Sperm Distinction Technology
Introduction
Bethany Naomi Deshpande is a notable inventor based in California. She has made significant contributions to the field of reproductive technology. Her innovative work focuses on distinguishing between X sperm and Y sperm, which has important implications for gender selection in reproductive procedures.
Latest Patents
Bethany holds a patent for a "System to distinguish between X sperm and Y sperm." This invention utilizes light scattering techniques to differentiate between the two types of sperm. Approximations to distinguish between X sperm and Y sperm are obtained by detecting light scattered into a pre-set angular range. The scattered light is produced by nuclei of sperm moving single-file in a sample container. Notably, the sperm are not modified prior to the light scattering and are not altered by the light scattering process. The accuracy of the approximations is enhanced by at least a second detection of scattered light. This innovative approach represents a significant advancement in the field.
Career Highlights
Bethany has dedicated her career to advancing reproductive technologies. Her work has garnered attention for its potential applications in fertility treatments. She continues to explore new avenues for innovation in this critical area of health and science.
Collaborations
Bethany has collaborated with notable individuals in her field, including Satish Deshpande and Donald Franklin Moyer. These partnerships have contributed to the development and refinement of her innovative technologies.
Conclusion
Bethany Naomi Deshpande is a pioneering inventor whose work in sperm distinction technology is paving the way for advancements in reproductive health. Her contributions are vital to the ongoing evolution of fertility treatments and gender selection methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile